NAMI Advocacy Actions

NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.


 
Comments to HHS Secretary on Medicaid & Maternal Mental Health
01/22/2021
Regulatory comments to HHS Acting Secretary Norris Cochran, expressing support for Georgia’s request to extend Medicaid postpartum coverage from 60 days to six months.
Coalition Comments to HHS Secretary on Medicaid
01/22/2021
Comments to HHS Acting Secretary Norris Cochran, expressing support for Georgia’s request to extend Medicaid postpartum coverage from 60 days to six months.
Statement on COVID-19
01/12/2021
Statement: Leading Mental Health Organizations Call on States to Prioritize Individuals in Psychiatric Hospitals for Vaccination.
Advocacy Resource on 988 Crisis Response Problems and Solutions
01/11/2021
Advocacy resource reviewing the problems with the current mental health crisis response and the solutions a 988 crisis response system offers to change how people experiencing crises get help.
Advocacy Resource on 988 Crisis Response System Vision
01/11/2021
Advocacy resource explaining the three pillars of a robust 988 crisis response system, including 24/7 crisis call centers, mobile crisis teams and crisis stabilization programs.
Letter to HHS Secretary on Medicaid
01/08/2021
Letter to HHS Secretary-Designate Becerra, urging to rescind guidance (SMD 18-002) to state Medicaid programs regarding work and community engagement requirements upon taking office.
Comments to HHS Secretary on Medicaid & Criminal Justice
01/08/2021
Regulatory comments to HHS Secretary Azar, expressing support for Kentucky’s Medicaid demonstration waiver amendment that would provide Medicaid coverage for substance use disorder (SUD) services for certain justice-involved individuals.
Letter to President Biden on Treatment Innovation
01/07/2021
Letter to President Biden, urging to rescind the human fetal tissue research restrictions and policy changes that the Department of Health and Human Services made in 2019.
Comments to CMS Administrator on Medication Access & Health Coverage
01/04/2021
Regulatory comments to CMS Administrator Verma on the Centers for Medicare and Medicaid Services’ (CMS) proposed rule refining prior authorization processes in Medicaid and Children’s Health Insurance Program (CHIP), and for health plans on the Federally-facilitated exchanges.
Displaying results 31-39 (of 39)
 <  1 - 2 - 3 - 4 >